WO2001085242A1 - Respiratory aid - Google Patents
Respiratory aid Download PDFInfo
- Publication number
- WO2001085242A1 WO2001085242A1 PCT/GB2001/001925 GB0101925W WO0185242A1 WO 2001085242 A1 WO2001085242 A1 WO 2001085242A1 GB 0101925 W GB0101925 W GB 0101925W WO 0185242 A1 WO0185242 A1 WO 0185242A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- respiratory aid
- visible radiation
- respiratory
- external surface
- during non
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
Definitions
- the present invention relates to a respiratory aid adapted to combat more effectively the symptoms of a subject with a respiratory disorder, in particular to an inhaler which is capable of emitting visible radiation (eg light) in any environment in which the level of ambient lighting alone is insufficient to render the respiratory aid visible (eg during non-daylight hours) .
- visible radiation eg light
- Various respiratory aids are now widely available to a subject wishing to self-administer therapeutip and preventative agents to combat the symptoms of a respiratory disorder such as asthma. These aids come in a range of shapes and sizes to suit the age and ability of the subject.
- Such respiratory aids include inhalers and auxiliary devices such as spacers, optimisation chambers, reservoirs, ' expansion chambers and deceleration chambers.
- a common example of a respiratory aid is the inhaler which is a manually operated device used to dispense into the respiratory passages a discrete amount of a therapeutic or preventative agent.
- a respiratory aid is the inhaler which is a manually operated device used to dispense into the respiratory passages a discrete amount of a therapeutic or preventative agent.
- aerosol powered by a propellant eg the metered dose inhaler
- powder containing device eg a metered does powder inhaler
- the therapeutic or preventative agent may be in dry powder or liquid (eg suspension) form.
- a particular example of an inhaler is the metered-dose inhaler which is described in inter alia GB-A- 2293110.
- the therapeutic or preventative agent is drawn into the respiratory passages by simultaneously dispensing the agent and taking a sharp intake of breath.
- an inhaler One of the benefits of an inhaler is that the subject is able to manage the respiratory disorder through self- administration of a preventative agent.
- a successful preventative regime relies on regular self-administration of the preventative agent to avert breathing difficulties and other respiratory symptoms.
- a second benefit of an inhaler is that sudden respiratory attacks may be treated by immediate self-administration of the desired therapeutic agent.
- the preventative and therapeutic benefits of the inhaler rely on the subject being able to locate the inhaler as effortlessly as possible. Breathing difficulties may occur suddenly and indiscriminately and their onset frequently leads to a loss in co-ordination. Loss in coordination can make actuation of even the most straightforward inhaler a difficult task and furthermore makes it difficult for the subject to effectively coordinate actuation of the inhaler with a sharp intake of breath.
- the overall effect on the subject is cumulative distress and panic causing a sharp deterioration in their welfare.
- a subject is particularly vulnerable to these factors during non-daylight hours when a respiratory aid may be less effortlessly located. This is especially true of an awakened subject who may already be in a disorientated state.
- the present invention is based on the recognition that the welfare of a subject having a respiratory disorder (such as asthma) may be improved by assisting them to locate a respiratory aid (eg an inhaler) during hours of darkness. More particularly, the present invention provides a light emitting respiratory aid which assists regular administration in a preventative regime and which enables rapid therapeutic administration at the onset of a respiratory attack.
- a respiratory aid eg an inhaler
- the present invention provides a respiratory aid for use in self-administration of an agent for combatting (eg preventing or treating) the symptoms of a respiratory disorder, said respiratory aid having an external surface at least a portion of which is capable of emitting visible radiation during non-daylight hours .
- the whole or a part of the external surface of the respiratory aid may be capable of emitting visible radiation during non-daylight hours.
- one or more components (or partial surfaces) of the respiratory aid may be selectively capable of emitting radiation during non-daylight hours (ie whilst the remaining components (or partial surfaces) are selectively incapable of emitting radiation during non-daylight hours) .
- the respiratory aid may be an inhaler or an auxiliary device.
- the invention is particularly advantageous where the respiratory aid .is an inhaler.
- Conventional inhalers are small (often pocket- sized) and therefore easily misplaced.
- the present invention is useful for any type of inhaler including pressurised metered dose inhalers (both manually operable and breath actuated) , aerosol inhalers and dry powder inhalers, for auxiliary devices including spacers and stands or for accessories .
- the respiratory aid is an inhaler comprising: a container for the agent (eg a pressurised cannister) ; and an actuator body adapted to permit manual dispensation of a therapeutically or preventatively effective amount of said agent through a delivery outlet directly or indirectly into the respiratory passages of a subject, said outlet being positionable in the subject's mouth or into an auxiliary device (such as a spacer or an optimisation chamber) .
- a container for the agent eg a pressurised cannister
- an actuator body adapted to permit manual dispensation of a therapeutically or preventatively effective amount of said agent through a delivery outlet directly or indirectly into the respiratory passages of a subject, said outlet being positionable in the subject's mouth or into an auxiliary device (such as a spacer or an optimisation chamber) .
- the delivery outlet may be selectively capable of emitting visible radiation during non-daylight hours thereby advantageously assisting the subject to identify more effortlessly the configuration of the aid during non-daylight hours.
- the container eg pressurised cannister
- the container may be selectively capable of emitting visible radiation during non-daylight hours thereby assisting the subject to replace more effortlessly a spent container during non-daylight hours.
- the portions of the external surface of the actuator body upon which the subject places its fingers may be selectively capable of emitting visible radiation during non-daylight hours to assist the subject to manually dispense agent more effortlessly.
- the delivery outlet may be capped with a cap.
- Either the cap or the body may be selectively capable of emitting visible radiation. If the cap is inseparable from the delivery outlet during use (for example in a breath actuated device) , it is preferred that the cap is selectively capable of emitting visible radiation (ie the body is incapable of emitting radiation during non-daylight hours) .
- the portion of the external surface is capable of emitting visible radiation over a period of 1-12 hours, preferably at least six hours, more preferably over at least eight hours, most particularly preferably over a period of at least ten hours.
- a surface means capable of emitting visible radiation during non-daylight hours is, applied to at least a portion of the external surface of the respiratory aid.
- the surface means may be applied to the portion of the external surface of the respiratory aid in the form of a layer or a coating.
- a paint, dye or ink capable of emitting radiation during non-daylight hours may be coated, printed or labelled onto at least a portion of the external surface of the respiratory aid.
- a printed label eg an adhesive label
- capable of emitting radiation during non-daylight hours may be applied to a least a portion of the external surface.
- the surface means is capable of exhibiting fluorescence, luminescence, chemiluminescence, electrochemiluininescence, bioluminescence, triboluminescence, mechanoluminescence or phosphorescence during non-daylight hours.
- the surface means comprises a fluorescent, luminescent, chemilu inescent, electrochemiluminescent, bioluminescent, triboluminescent, mechanoluminescent or phosphorescent material.
- the body of the respiratory aid is intrinsically capable of emitting visible radiation during non-daylight hours.
- the body of the respiratory aid may be caused to emit visible radiation by a physical, biological or chemical stimulus.
- the physical stimulus may be- electrical, thermal, mechanical or electromagnetic.
- the chemical stimulus may be a chemical reaction or chemical interaction.
- the body of the respiratory aid is intrinsically capable of exhibiting fluorescence, luminescence, chemiluminescence, electrochemiluminescence, bioluminescence, triboluminescence, mechanoluminescence or phosphorescence during non-daylight hours.
- this is achieved intrinsically by incorporating into the body of the respiratory aid a fluorescent, luminescent, chemiluminescent, electrochemilu inescent, bioluminescent, triboluminescent, mechanoluminescent or phosphorescent material (or a material capable of inducing one of these phenomena) .
- the body of the respiratory aid may comprise an organic or inorganic material capable of emitting visible radiation (or of causing visible radiation to be emitted) during non- daylight hours.
- an inorganic or organic material (“the guest material”) may be incorporated into the material of the body ("the host material''-') .
- the host material is a polymer.
- the host material may be capable of emitting visible radiation (or of causing visible radiation to be emitted) during non-daylight hours.
- the guest material may be capable of emitting visible radiation (or of causing visible radiation to be emitted) during non-daylight hours.
- organic materials include inter alia polyethers, polyacrylates, conjugated polymers (polyaromatics, polyvinyls or polyarylenevinylenes) and polythiophenes .
- the host and the guest material are polymeric (eg the body of the respiratory aid comprises a mixture of a first and second polymer) .
- One of the first and second polymers is capable of emitting visible radiation (or of causing visible radiation to be emitted) during non-daylight hours.
- Methods for manufacturing a body composed of a mixture of polymers are familiar to those skilled in the art (eg moulding techniques) .
- An example of an inorganic material is zinc sulphide optionally doped with a transition metal (manganese) .
- inorganic materials which may be useful may include a rare earth element selected from the group consisting of europium (EuII, EuIII, Eu 2+ or Eu 3+ ) , erbium (ErIII or Er 3+ ) , ytterbium (Ybll or Yb 2+ ) , cerium (Celll or Ce 3+ ) , praseodymium (Prill or Pr 3+ ) , gadolinium (Gdlll or Gd 3+ ) and samarium (S ll or Sm 2+ ) .
- a rare earth element selected from the group consisting of europium (EuII, EuIII, Eu 2+ or Eu 3+ ) , erbium (ErIII or Er 3+ ) , ytterbium (Ybll or Yb 2+ ) , cerium (Celll or Ce 3+ ) , praseodymium (Prill or Pr 3+ ) , gadolinium (
- inorganic materials which may be useful may include a transition metal selected from the group consisting of ruthenium (RuII, RuIII, Ru 2+ or Ru 3+ ) or chromium (CrII, CrIII, CrNI, Cr 2+ , Cr 3+ or Cr 6+ ) .
- the transition metal or rare earth metal may be complexed with an appropriate counter-ion.
- Other inorganic materials which may be useful include Si0 2 , SiC, GaAs or Si.
- luminescent materials suitable for use in the invention are known in the art. Such materials are disclosed inter alia in Luminescent Materials: G Blasse and B C Grab aier, 1/9/94 (Springer-Nerlag ISB ⁇ 3540580190) and in SPIE, volume 675, 1999, page 169. Guest luminescent materials which can be incorporated into a host polymeric body (eg a plastic) are well known.
- Phosphorescent materials suitable for use in the invention are typically an organic material (eg an aromatic material) optionally containing an inorganic guest material.
- an inorganic moiety eg an ion
- an organic (eg aromatic) chromophore accepts energy from an organic (eg aromatic) chromophore.
- Electrochemiluminescent suitable for use in the invention are typically organic based materials (for example see J. of Phys. D (Applied Physics), 1999, Vol 32, 24, R179- R249) . Other electrochemiluminescent materials are discussed in general in Trends in Analytical Chemistry, 1999, Vol 18, 1, 47-62.
- Figure 1 represents a respiratory aid in the form of an inhaler in accordance with an embodiment of the invention.
- Figure 1 illustrates a respiratory aid in the form of an inhaler designated generally by reference numeral 1 for use by subjects with respiratory disorders.
- the inhaler comprises an actuator body 2 terminating in a mouth portion 3 with an outlet 5 and a container 4 from which a dose of therapeutic or preventative medicament may be dispensed.
- the exterior surface of the actuator body 2 and mouth piece 3 are coated with a fluorescent material which makes the device visible during hours of darkness and more effortlessly located by subjects.
- the body or cap may be selectively capable of emitting visible radiation, particularly if the body and cap are not separable during use (for example in a breath actuated device) .
- Auxiliary items such as spacers or canisters may also be selectively capable of emitting visible radiation.
- an external surface at least a portion of which is capable of emitting visible radiation during non-daylight hours is intended to include a surface which is capable of emitting visible radiation in any environment in which the level of ambient lighting alone is insufficient to render the respiratory aid visible.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001252391A AU2001252391A1 (en) | 2000-05-08 | 2001-05-03 | Respiratory aid |
EP01925707A EP1280577A1 (en) | 2000-05-08 | 2001-05-03 | Respiratory aid |
CA002405759A CA2405759A1 (en) | 2000-05-08 | 2001-05-03 | Respiratory aid |
JP2001581895A JP2003532501A (en) | 2000-05-08 | 2001-05-03 | Breathing aid |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0010995.9 | 2000-05-08 | ||
US20298600P | 2000-05-09 | 2000-05-09 | |
US60/202,986 | 2000-05-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001085242A1 true WO2001085242A1 (en) | 2001-11-15 |
Family
ID=22751996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/001925 WO2001085242A1 (en) | 2000-05-08 | 2001-05-03 | Respiratory aid |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2001085242A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019216858A3 (en) * | 2018-04-05 | 2020-02-06 | Duendaroez Mehmet Rusen | Safe endotracheal and tracheostomy tube |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB402777A (en) * | 1932-02-27 | 1933-11-27 | Frederic William Vesey Fitzger | Improved means for and methods of manufacturing, utilising and applying phosphorescent compounds |
US5007924A (en) * | 1989-08-09 | 1991-04-16 | Jekel Tina M | Luminescent pacifier |
US5388730A (en) * | 1993-11-10 | 1995-02-14 | Enviro Pac International L.L.C. | Lockable actuator for a dispensing canister |
GB2327660A (en) * | 1997-07-30 | 1999-02-03 | Alan Barker | Luminescent condoms and packaging thereof |
US5979442A (en) * | 1994-08-17 | 1999-11-09 | Orr; Rodney J. | Emergency breathing device, and methods of constructing and utilizing same |
-
2001
- 2001-05-03 WO PCT/GB2001/001925 patent/WO2001085242A1/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB402777A (en) * | 1932-02-27 | 1933-11-27 | Frederic William Vesey Fitzger | Improved means for and methods of manufacturing, utilising and applying phosphorescent compounds |
US5007924A (en) * | 1989-08-09 | 1991-04-16 | Jekel Tina M | Luminescent pacifier |
US5388730A (en) * | 1993-11-10 | 1995-02-14 | Enviro Pac International L.L.C. | Lockable actuator for a dispensing canister |
US5979442A (en) * | 1994-08-17 | 1999-11-09 | Orr; Rodney J. | Emergency breathing device, and methods of constructing and utilizing same |
GB2327660A (en) * | 1997-07-30 | 1999-02-03 | Alan Barker | Luminescent condoms and packaging thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019216858A3 (en) * | 2018-04-05 | 2020-02-06 | Duendaroez Mehmet Rusen | Safe endotracheal and tracheostomy tube |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5686022A (en) | Phosphorescent phosphor | |
JP2543825B2 (en) | Luminescent phosphor | |
US4544997A (en) | Low-pressure mercury vapor discharge lamp | |
CN106978181B (en) | Near-infrared light charging up-conversion-long afterglow orthogonal fluorescence coding anti-counterfeiting material | |
JP2001202827A (en) | Method of manufacturing transparent conductive substrate, light emission device, plane light emission plate and manufacturing method of plane light emission plate, plane fluorescent lamp, and plasma display | |
IL158955A0 (en) | An aerosol forming device for use in inhalation therapy | |
CN108348701B (en) | System with atomizer and container | |
WO2001085242A1 (en) | Respiratory aid | |
TW525208B (en) | Fluorescent lamp, its manufacturing method, and liquid crystal display using the same | |
KR890006787A (en) | Luminescent composition | |
EP1280577A1 (en) | Respiratory aid | |
US20070263377A1 (en) | Luminescent lamp shade | |
JP3792731B2 (en) | Layered body having phosphorescent properties, method for producing the same, and use thereof | |
JP2006116779A (en) | Information display sheet | |
WO2010115762A1 (en) | Pen-type drug delivery device with luminous markers | |
KR100539832B1 (en) | Phosphorescent film | |
JPH09319307A (en) | Light-emissive sign panel and its label, transfer sheet and card | |
US4578618A (en) | Low-pressure, hollow cathode lamp | |
US10830395B1 (en) | Chemiluminescent light source | |
GB2604891A (en) | Phosphorescent payload members and respective dispenser devices for discharging and exciting the same | |
JPH11281764A (en) | Ornamental member and timepiece provided therewith | |
JP2006299225A (en) | Phosphor for plasma display panel and plasma display panel having fluorescent film formed with the phosphor | |
US20070096635A1 (en) | Long-Afterglow Electroluminescent Lamp | |
JP6551140B2 (en) | Card and method of manufacturing card | |
EP1737021A3 (en) | Doped dysprosia discharge vessel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2405759 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001925707 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001252391 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2001925707 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001925707 Country of ref document: EP |